Therapeutic and prophylactic activity of itraconazole against human rhinovirus infection in a murine model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Shim, Aeri ^a   Song, Jae Hyoung ^a   Kwon, Bo Eun ^a   Lee, Jeong Jun ^a   Ahn, Jae Hee ^a   Kim, Yeon Jeong ^b   Rhee, Ki Jong ^c   Chang, Sun Young ^d   Cha, Younggil ^a   Lee, Yong Soo ^e   Kweon, Mi Na ^e   Park, Kwi Sung ^f   Kim, Dong Eun ^g   Cho, Sungchan ^g   Cho, Hyun Jong ^a   Ko, Hyun Jeong ^a  

^a Kangwon National University   (South Korea)

^b Inje University   (South Korea)

^c Yonsei University Wonju   (South Korea)

^d Ajou University   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Chungcheongnam Do Institute of Health and Environmental Research   (South Korea)

^g Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHOLESTEROL; CYTOKINE; ITRACONAZOLE;

ANIMAL; BAGG ALBINO MOUSE; BRONCHOALVEOLAR LAVAGE FLUID; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FEMALE; LUNG; METABOLISM; PHYSIOLOGY; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL MEMBRANE; CHOLESTEROL; CYTOKINES; FEMALE; ITRACONAZOLE; LUNG; MICE, INBRED BALB C; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; VIRUS REPLICATION;

EID: 84961189257     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23110     Document Type: Article

References (42)

1. Palmenberg, A. C., Rathe, J. A. & Liggett, S. B. Analysis of the complete genome sequences of human rhinovirus. J Allergy Clin Immunol 125, 1190-1199 (2010).
2. Greenberg, S. B. Respiratory consequences of rhinovirus infection. Arch Intern Med 163, 278-284 (2003).
3. Fendrick, A. M., Monto, A. S., Nightengale, B. & Sarnes, M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 163, 487-494 (2003).
4. Roelen, C. A., Koopmans, P. C., Notenbomer, A. & Groothoff, J. W. Job satisfaction and short sickness absence due to the common cold. Work 39, 305-313 (2011).
5. Friedlander, S. L. & Busse, W. W. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 116, 267-273 (2005).
6. Corne, J. M. et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359, 831-834 (2002).
7. Contoli, M. et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12, 1023-1026 (2006).
8. Jacobs, S. E., Lamson, D. M., St George, K. & Walsh, T. J. Human rhinoviruses. Clin Microbiol Rev 26, 135-162 (2013).
9. Sozen, H. et al. Evaluation of the protective effect of silibinin in rats with liver damage caused by itraconazole. Cell Biochem Biophys 14, 14 (2014).
10. Saag, M. S. & Dismukes, W. E. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 32, 1-8 (1988).
11. McKinsey, D. S. et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 28, 1049-1056 (1999).
12. Graybill Md, J. R. et al. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients. Am J Med 104, 33-39 (1998).
13. Murray, P. A., Koletar, S. L., Mallegol, I., Wu, J. & Moskovitz, B. L. Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients. Clin Ther 19, 471-480 (1997).
14. Tuccori, M. et al. Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis. Ann Pharmacother 42, 1112-1117 (2008).
15. Wang, H. F. et al. [Severe viral hepatitis complicated with pleural aspergillus infection treated with itraconazole and amphotericin B]. Zhonghua Gan Zang Bing Za Zhi 14, 690-691 (2006).
16. Adriaenssens, B., Roskams, T., Steger, P. & Van Steenbergen, W. Hepatotoxicity related to itraconazole: report of three cases. Acta Clin Belg 56, 364-369 (2001).
17. Liu, R. et al. Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking. Autophagy 10, 1241-1255 (2014).
18. Xu, J., Dang, Y., Ren, Y. R. & Liu, J. O. Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci USA 107, 4764-4769 (2010).
19. Grassme, H., Riehle, A., Wilker, B. & Gulbins, E. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem 280, 26256-26262 (2005).
20. Snyers, L., Zwickl, H. & Blaas, D. Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis. J Virol 77, 5360-5369 (2003).
21. Yancey, P. G. et al. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration Of kinetic pools and mechanism of efflux. J Biol Chem 271, 16026-16034 (1996).
22. Xiao, C. et al. Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule. J Virol 78, 10034-10044 (2004).
23. Hastings, G. Z., Rowlands, D. J. & Francis, M. J. Proliferative responses of T cells primed against human rhinovirus to other rhinovirus serotypes. J Gen Virol 72, 2947-2952 (1991).
24. Vlasak, M. et al. The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J Virol 79, 7389-7395 (2005).
25. Bartlett, N. W. et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 14, 199-204 (2008).
26. Subauste, M. C., Jacoby, D. B., Richards, S. M. & Proud, D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96, 549-557 (1995).
27. Saklatvala, J. et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 271, 6586-6589 (1996).
28. Wickert, L. E., Karta, M. R., Audhya, A., Gern, J. E. & Bertics, P. J. Simvastatin attenuates rhinovirus-induced interferon and CXCL10 secretion from monocytic cells in vitro. J Leukoc Biol 95, 951-959 (2014).
29. Roulin, P. S. et al. Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. Cell Host Microbe 16, 677-690 (2014).
30. De Palma, A. M., Vliegen, I., De Clercq, E. & Neyts, J. Selective inhibitors of picornavirus replication. Med Res Rev 28, 823-884 (2008).
31. Daelemans, D., Pauwels, R., De Clercq, E. & Pannecouque, C. A time-of-drug addition approach to target identification of antiviral compounds. Nat Protoc 6, 925-933 (2011).
32. Iikura, M. et al. The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice. PLoS ONE 10, e0123584 (2015).
33. Siljamaki, E. et al. Cholesterol dependence of collagen and echovirus 1 trafficking along the novel alpha2beta1 integrin internalization pathway. PLoS ONE 8, e55465 (2013).
34. Strating, J. R. et al. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Rep 10, 600-615 (2015).
35. Tucker, R. M., Haq, Y., Denning, D. W. & Stevens, D. A. Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother 26, 561-566 (1990).
36. Song, J. H., Park, K. S., Kwon, D. H. & Choi, H. J. Anti-human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa. J Med Food 16, 274-279 (2013).
37. Song, J. et al. Antiviral activity of hederasaponin B from Hedera helix against Enterovirus 71 subgenotypes C3 and C4a. Biomol Ther 22, 41-46 (2014).
38. Seo, S. U. et al. MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection. J Virol 84, 12713-12722 (2010).
39. Seo, S. U. et al. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog 7, 24 (2011).
40. Kim, E. et al. The effect of rhinovirus on airway inflammation in a murine asthma model. Korean J Pediatr 56, 482-489 (2013).
41. Blanco, J. C. et al. Prophylactic antibody treatment and intramuscular immunization reduce infectious human rhinovirus 16 load in the lower respiratory tract of challenged cotton rats. Trials Vaccinol 3, 52-60 (2014).
42. Underwood, S., Foster, M., Raeburn, D., Bottoms, S. & Karlsson, J. A. Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir J 8, 2104-2113 (1995).